Listonstreetpulse.com announces that Arrayit Corporation’s (OTC: ARYC) senior management will start buying common shares of ARYC on the open market. Arrayit Chairman and Chief Executive Officer Rene Schena, Arrayit President and Chief Science Officer Dr. Mark Schena, and Arrayit Co-Founder and Executive Vice President Todd Martinsky will start open market purchases of ARYC stock in accordance with the rules that guide such transactions set by the U.S. Securities and Exchange Commission (SEC), including the filing of Form 4 documents.
Arrayit President Dr. Mark Schena notes, “As a profitable microarray technology leader, Arrayit is well-positioned to capitalize on growth opportunities in the life sciences and diagnostics sectors, and we believe that ARYC is undervalued based on historical trading prices, market cap, multiple of sales, multiple of earnings, and the company’s product portfolio, customer base and product pipeline. Today’s $0.43 per share stock price enables senior management to add shares of ARYC to its personal portfolios at an attractive market entry point.”
On April 6, 2009, ARYC shares traded at an all-time high of $5 per share. Since July 17, 2013, the stock has surged 391% on record daily and quarterly trading volume. Recent company announcements include a new funding source and the addition of renowned Wall Street analyst and biotech expert Sid Taubenfeld to the Arrayit Board of Directors.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
